Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Researchers at the Gladstone Institutes and the University of California, San Francisco, are evaluating next-generation sequencing for its ability to detect early signs of drug resistance in HIV patients. In an Illumina-sponsored webinar, Gordon Bentley, a senior research associate at Gladstone, discussed his group's use of deep amplicon sequencing of the HIV reverse transcriptase gene to look for known mutations conferring resistance to antiretroviral drugs.
In the race for a cure for HIV, the wins are stacking up. Scientists are searching for a cure that's affordable and safe, and will shut down the epidemic entirely.
Researchers at San Francisco's Gladstone Institutes are being awarded more than $12 million in grants from divisions of the National Institutes of Health to help develop an elusive knock-out punch against AIDS.
Gladstone's Warner C. Greene comments on the search for an HIV cure, in an article that surveys a variety of cure research projects currently underway.
When Katie Pollard, Ph.D., looks through a microscope, she often sees something familiar staring back. It's a unique population known as our microbiome -- the microbes that live in our stomachs and could potentially improve our health if we treat them right.
A disease with no cure that is linked to old age can be written off as simply inevitable. But we have a real opportunity to change that - and we are closer to doing so than ever before.
Gladstone bioninformatics expert Katie Pollard sits down with science and health innovators to discuss the future of medicine in the 21st century.
For video scroll to Wednesday, September 11th, "The New Diagnosis."
Gladstone's Deepak Srivastava comments on research in which scientists reprogram cells inside living mice -- and discover that the pluripotent stem cells created in the process are even more flexible than those derived from embryos or grown in laboratory dishes.
Are we on the cusp of curing HIV/AIDS? The Gladstone Institutes joins with leaders from CIRM, UCSF and others to engage the community in an interactive forum on cure research on October 1.
Heart disease, a leading cause of death in the U.S., costs billions, literally, in terms of services, medications, and lost productivity. Now, researchers have developed a new technique that “personalizes” treatment for those suffering from heart disease — a gene therapy approach that would be able to convert cells into heart muscle cells.